NVIDIA Corporation (NASDAQ: NVDA) reports Q3 FY2027 total revenue exceeding USD 68.0 billion in its quarterly earnings report (approx. November 19, 2026, confirmed via NVIDIA IR or Bloomberg by November 20, 2026)
Pending
✦ AI-generated prediction
Published on 1. October 2026
·
Predicted for 19. November 2026
·
Based on: Historical Cycle
NVIDIA delivered $57.01B in Q3 FY2026 (Aug–Oct 2025), beating consensus of $54.92B by 3.3%. At a conservative ~19% YoY growth rate for Q3 FY2027 (Aug–Oct 2026), the target lands at ~$67.9B — placing the $68.0B threshold squarely at the consensus midpoint. Supporting: Microsoft Azure and Google Cloud continued double-digit AI capex growth in Q3 2026; Alphabet reported >$18B capex in Q3 2026. Headwind: US export restrictions on H20 chips to China cap upside. No dedicated Polymarket/Kalshi product for NVIDIA Q3 FY2027.
Data basis for this prediction
- NVIDIA Q3 FY2026 Umsatz: 57,01 Mrd. USD (vs. Konsens 54,92 Mrd., +3,3 % Beat) — CNBC / Futurum, 19. November 2025
- NVIDIA Q4 FY2026 Umsatzguidance: ~65 Mrd. USD — NVIDIA Investor Relations, November 2025
- Microsoft Azure Capex Q1 FY2027: zweistelliges YoY-Wachstum — Microsoft IR, Oktober 2026
- Alphabet Q3 2026 Capex: >18 Mrd. USD, KI-fokussiert — Alphabet IR / Bloomberg, Oktober 2026
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
💻 Technology
✦ AI
ETH is at ~2,700–2,717 USD on Oct 1 (Coinbase / Investing.com). Reaching >3,000 USD by Oct 31 requires +11 % in 30 days. The 2,800 USD level is the critical breakout resistance (usethebitcoin.com). The projection is internally consistent with open platform predictions (ETH >3,200 by Dec 31 2026, ETH >3,500 by Mar 31 2027), implying passage through 3,000 en route. BTC at ~84,000 USD with an open upward prediction for Oct 4 (>86,000) supports broader crypto momentum. Headwinds: PCE inflation data weighed on ETH recently; ETH/BTC ratio shows relative underperformance. No specific Polymarket data for this exact date/level; Cassandra estimates 42 %.
💻 Technology
✦ AI
Ethereum trades at $2,680 on Oct 1, 2026 (CoinGecko). The $3,500 threshold is 30.6% above current price — achievable within 6 months but ambitious. Forecaster consensus for October 2026 alone: DailyForex $2,600–$3,100; CoinDCX $2,950; Changelly $3,045–$3,070 (minimum target). The $3,500 level thus represents a natural projection of October momentum into Q1 2027. Bullish drivers: ETH staking yields remain attractive; Layer-2 adoption (Base, Arbitrum, Optimism) accelerates network utilization; historical BTC halving cycle patterns favor altcoin rallies from Q4 2026. Headwinds: US SEC regulatory action, macro-driven risk aversion, or decoupling from BTC. No direct Polymarket market found for this horizon; 30% probability conservatively derived from forecaster spread and ETH volatility profile.
💻 Technology
✦ AI
The Royal Swedish Academy of Sciences announces the Nobel Prize in Chemistry on October 7. Shankar Balasubramanian and David Klenerman (both University of Cambridge) are the main favorites on small, illiquid prediction markets (Kalshi, Polymarket) for their invention of Sequencing by Synthesis (SBS), the foundation of modern NGS platforms — above all Illumina — which has revolutionized personalized medicine, oncology, and infectious disease epidemiology. Other strongly backed candidates: Pieter Cullis (UBC) for lipid nanoparticle technology (mRNA vaccines) and the skeletal editing trio Sarpong/Levin/Miranda. Kalshi: Balasubramanian/Klenerman as frontrunners without published exact odds; market positioning per Chemistry World and The Scientist implies approximately 20–28% for this duo. Nobel committees historically act surprisingly; probability set at 25%.